Target intelligence / Profile preview

Cluster of differentiation antigen (CD antigen (for specific molecules, e.g., CD4, CD8, etc.))

Target
CD antigen (for specific molecules, e.g., CD4, CD8, etc.)
Molecular classification
Receptor, Ligand, Cell surface marker, Glycoprotein, Adhesion molecule, Other (depending on specific CD member)
01

Overview

Differentiation antigens (most commonly referred to as Cluster of Differentiation or CD antigens) are molecules present on the membranes of living cells, whose expression reflects distinct stages of cell maturation and differentiation, particularly within the immune system. These antigens serve as important cell markers for immunophenotyping, play essential roles in cell signaling, cell adhesion, and immune response, and are frequently used as diagnostic and therapeutic targets in diseases such as cancer and autoimmune disorders. Individual CD antigens are associated with particular cell types (e.g., CD4 on helper T cells, CD8 on cytotoxic T cells) and their identification is fundamentally important for clinical and research immunology.

Other names
Cluster of differentiationCD antigenT-cell differentiation antigenclassification determinantcluster of designation
02

Mechanism of action

Drug mechanisms include antibody-dependent cell-mediated cytotoxicity, complement-dependent cytotoxicity, and immune modulation—mechanisms are specific to each CD target.

03

Biological functions

Cell signaling (signal transduction)Immune responseCell adhesionCell proliferationCell differentiationIdentification of cell subsets (immunophenotyping)
04

Disease associations

Cancer (neoplastic transformation, tumor immunophenotyping)Inflammation (immune activation)Infection (immune cell tracking, pathogen response)Other (immune dysregulation diseases)
05

Safety considerations

ImmunosuppressionOff-target cytotoxicityCytokine release syndromeSpecific concerns depend on which CD antigen is targeted
06

Interacting drugs

Varies by individual CD molecule (e.g., rituximab targets CD20, alemtuzumab targets CD52, daratumumab targets CD38). "Differentiation antigen" as a class does not specify drugs.
07

Biomarkers

Cell type identificationDisease diagnosisPrognosisTherapeutic monitoring

Beyond the preview

Go deeper on Cluster of differentiation antigen (CD antigen (for specific molecules, e.g., CD4, CD8, etc.)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cluster of differentiation antigen (CD antigen (for specific molecules, e.g., CD4, CD8, etc.)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call